Natural history of Niemann-Pick disease type C in a multicentre observational retrospective cohort study

被引:80
作者
Wraith, J. E. [1 ]
Guffon, N. [2 ]
Rohrbach, M. [3 ]
Hwu, W. L. [4 ]
Korenke, G. C. [5 ]
Bembi, B. [6 ]
Luzy, C. [7 ]
Giorgino, R. [7 ]
Sedel, F. [8 ,9 ]
机构
[1] Royal Manchester Childrens Hosp, Willink Biochem Genet Unit, Manchester M27 4HA, Lancs, England
[2] Hosp Civils Lyon, Reference Ctr Metab Dis, CERLYMM, Lyon, France
[3] Kinderspital Zurich, CH-8032 Zurich, Switzerland
[4] Natl Taiwan Univ Hosp, Taipei, Taiwan
[5] Elisabeth Kinderkrankenhaus, Oldenburg, Germany
[6] Univ Hosp, Reg Coordinator Ctr Rare Dis, Udine, Italy
[7] Actel Pharmaceut Ltd, Allschwil, Switzerland
[8] Hop La Pitie Salpetriere, Paris, France
[9] Reference Ctr Lysosomal Dis, Paris, France
关键词
Niemann-Pick disease type C; NP-C; Natural history; Disease progression; GALACTOSYL HYDROLASE DEFICIENCY; CHOLESTEROL; LACTOSYLCERAMIDE;
D O I
10.1016/j.ymgme.2009.06.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Niemann-Pick disease type C (NP-C) is a devastating genetic disorder characterised by progressive neurological deterioration. However, data on the progression of neurological manifestations, particularly across different patient age-of-disease onsets, are limited. This is an observational retrospective cohort study designed to assess the progression of neurological disease in patients with NP-C. Physicians were asked to retrospectively complete a web-based questionnaire for each patient, at diagnosis and at up to three follow-up visits. An NP-C-specific disability scale was used to measure disease progression. The scale comprised four key parameters of neurological disease progression; ambulation, manipulation, language and swallowing. Disease progression was evaluated based on the annual rate of change in each parameter and the composite score using a linear mixed model analysis, and by classifying patients according to the number of worsened parameters during the observation period. Data were collected from 57 patients. The rate of deterioration was similar across the four individual parameters of the disability scale. The mean (95% CI) annual disease progression was +0.12 (0.09, 0.15) units. Among patients with a time interval of at least I year between diagnosis and last visit (n = 49), 42 (86%) patients had progressed disease and 7 (14%) patients had stable disease. Disease progression was consistently more rapid in patients diagnosed in early childhood, compared with those diagnosed in late childhood, or with juvenile or adult presentation. In conclusion, our findings showed a progression in all four parameters of the disability scale, representing a continuous, unbroken progression of neurological manifestations. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:250 / 254
页数:5
相关论文
共 23 条
[1]   NIEMANN-PICK DISEASE TYPE-C AND TYPE-D [J].
BRADY, RO ;
FILLINGKATZ, MR ;
BARTON, NW ;
PENTCHEV, PG .
NEUROLOGIC CLINICS, 1989, 7 (01) :75-88
[2]   Niemann-Pick C1 disease gene: Homology to mediators of cholesterol homeostasis [J].
Carstea, ED ;
Morris, JA ;
Coleman, KG ;
Loftus, SK ;
Zhang, D ;
Cummings, C ;
Gu, J ;
Rosenfeld, MA ;
Pavan, WJ ;
Krizman, DB ;
Nagle, J ;
Polymeropoulos, MH ;
Sturley, SL ;
Ioannou, YA ;
Higgins, ME ;
Comly, M ;
Cooney, A ;
Brown, A ;
Kaneski, CR ;
BlanchetteMackie, EJ ;
Dwyer, NK ;
Neufeld, EB ;
Chang, TY ;
Liscum, L ;
Strauss, JF ;
Ohno, K ;
Zeigler, M ;
Carmi, R ;
Sokol, J ;
Markie, D ;
ONeill, RR ;
vanDiggelen, OP ;
Elleder, M ;
Patterson, MC ;
Brady, RO ;
Vanier, MT ;
Pentchev, PG ;
Tagle, DA .
SCIENCE, 1997, 277 (5323) :228-231
[3]   LACTOSYLCERAMIDOSIS - LACTOSYLCERAMIDE GALACTOSYL HYDROLASE DEFICIENCY AND ACCUMULATION OF LACTOSYLCERAMIDE IN CULTURED SKIN FIBROBLASTS [J].
DAWSON, G ;
MATALON, R ;
STEIN, AO .
JOURNAL OF PEDIATRICS, 1971, 79 (03) :423-+
[4]  
DAWSON G, 1972, J LIPID RES, V13, P207
[5]   The National Niemann-Pick C1 Disease Database: Report of clinical features and health problems [J].
Garver, William S. ;
Francis, Gordon A. ;
Jelinek, David ;
Shepherd, Glen ;
Flynn, James ;
Castro, Graciela ;
Vockley, Cate Walsh ;
Coppock, Donald L. ;
Pettit, Kathleen M. ;
Heidenreich, Randy A. ;
Meaney, F. John .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2007, 143A (11) :1204-1211
[6]  
HARZER K, 1978, ACTA NEUROCHIR, V43, P97
[7]   The natural history of Niemann-Pick disease type C in the UK [J].
Imrie, J. ;
Dasgupta, S. ;
Besley, G. T. N. ;
Harris, C. ;
Heptinstall, L. ;
Knight, S. ;
Vanier, M. T. ;
Fensom, A. H. ;
Ward, C. ;
Jacklin, E. ;
Whitehouse, C. ;
Wraith, J. E. .
JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 (01) :51-59
[8]   Niemann-Pick C disease in Spain:: Clinical spectrum and development of a disability scale [J].
Iturriaga, C. ;
Pineda, M. ;
Fernandez-Valero, E. M. ;
Vanier, M. T. ;
Coll, M. J. .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 249 (01) :1-6
[9]   Intracellular trafficking of Niemann-Pick C proteins 1 and 2: obligate components of subcellular lipid transport [J].
Liscum, L ;
Sturley, SL .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2004, 1685 (1-3) :22-27
[10]   FETAL ASCITES - AN UNUSUAL PRESENTATION OF NIEMANN-PICK DISEASE TYPE-C [J].
MANNING, DJ ;
PRICE, WIJ ;
PEARSE, RG .
ARCHIVES OF DISEASE IN CHILDHOOD, 1990, 65 (03) :335-336